[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS5813526B2 - Grasshopper's garden - Google Patents

Grasshopper's garden

Info

Publication number
JPS5813526B2
JPS5813526B2 JP3500874A JP3500874A JPS5813526B2 JP S5813526 B2 JPS5813526 B2 JP S5813526B2 JP 3500874 A JP3500874 A JP 3500874A JP 3500874 A JP3500874 A JP 3500874A JP S5813526 B2 JPS5813526 B2 JP S5813526B2
Authority
JP
Japan
Prior art keywords
salts
cloxacillin
cefazolin
grasshopper
garden
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP3500874A
Other languages
Japanese (ja)
Other versions
JPS50126816A (en
Inventor
上村利明
西田実
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to JP3500874A priority Critical patent/JPS5813526B2/en
Priority to IT6748475A priority patent/IT1036078B/en
Priority to FR7506201A priority patent/FR2262519B1/fr
Priority to DE19752508443 priority patent/DE2508443C2/en
Priority to GB832775A priority patent/GB1479838A/en
Priority to NL7502333A priority patent/NL180071C/en
Priority to AU78654/75A priority patent/AU490435B2/en
Priority to CA221,406A priority patent/CA1038759A/en
Priority to DK132675A priority patent/DK132675A/da
Publication of JPS50126816A publication Critical patent/JPS50126816A/ja
Publication of JPS5813526B2 publication Critical patent/JPS5813526B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 この発明はセファゾリンもしくはその塩類1重量部およ
びクロキサシリンもしくはその塩類約1〜1000重量
部を含む新規な牛乳房炎用殺菌粗成物に関するものであ
る。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel antiseptic crude product for bovine mastitis containing 1 part by weight of cefazolin or a salt thereof and about 1 to 1000 parts by weight of cloxacillin or a salt thereof.

セファゾリンもしくはその塩類およびクロキサシリンも
しくはその塩類は、それぞれ広範囲な抗菌スペクトラム
を有する抗生物質としてよく知られている。
Cefazolin or its salts and cloxacillin or its salts are well known as antibiotics each having a broad antibacterial spectrum.

この発明者等は鋭意研究の結果、セファゾリンもしくは
その塩類およびクロキサシリンもしくはその塩類が協力
作用を有しているという新知見を得、この発明を完成し
た。
As a result of intensive research, the inventors obtained the new finding that cefazolin or its salts and cloxacillin or its salts have a synergistic effect, and completed this invention.

この発明の目的の一つは、セファゾリンもしくはその塩
類およびクロキサシリンもしくはその塩類をそれぞれ単
独で使用した場合には、抗菌活性を示さないかあるいは
ほとんど示さない病原菌、殊に、プロテウス等の如きダ
ラム陰性菌に対して、セファゾリンもしくはその塩類お
よびクロキサシリンもしくはその塩類を併用することに
より強力な抗菌活性を示す有効な牛乳房炎用殺菌組成物
を提供することにある。
One of the objects of the present invention is that when cefazolin or its salts and cloxacillin or its salts are used alone, pathogenic bacteria, particularly Durham-negative bacteria such as Proteus, which exhibit no or almost no antibacterial activity. An object of the present invention is to provide an effective bactericidal composition for bovine mastitis that exhibits strong antibacterial activity by using cefazolin or its salts and cloxacillin or its salts in combination.

また他の目的は、セファゾリンもしくはその塩類および
クロキサシリンもしくはその塩類のそれぞれに耐性を示
す病原菌に対して有効な牛乳房炎用殺菌組成物を提供す
ることにある。
Another object of the present invention is to provide a bactericidal composition for bovine mastitis that is effective against pathogenic bacteria that are resistant to cefazolin or its salts and cloxacillin or its salts.

さらに他の目的は、殺菌速度を促進し、治療効果を高め
る牛乳房炎用殺菌組成物を提供することにある。
Yet another object is to provide a disinfectant composition for bovine mastitis that accelerates the disinfection rate and enhances the therapeutic effect.

この発明は、セファゾリンもしくはその塩類およびクロ
キサシリンもしくはその塩類を含む牛乳房炎用殺菌組成
物であるが、ここで塩類としては例えばナトリウム、カ
リウム、カルシウム等の金属塩、アンモニウム塩および
トリメチルアミン、トリエチルアミン、プロカイン、ジ
ベンジルアミン塩等の通常セファロスポリンおよびペニ
シリンの塩として用いられる塩が挙げられる。
The present invention is a sterilizing composition for bovine mastitis containing cefazolin or its salts and cloxacillin or its salts, where the salts include, for example, metal salts such as sodium, potassium, and calcium, ammonium salts, and trimethylamine, triethylamine, and procaine. and dibenzylamine salts, which are commonly used as salts of cephalosporins and penicillins.

この発明の動物用殺菌組成物は、公知のペニシリン製剤
等抗生物質製剤と同様な剤形、使用方法で用いられるが
、注乳剤として使用するのが適当である。
The sterilizing composition for animals of the present invention can be used in the same dosage form and method of use as known antibiotic preparations such as penicillin preparations, but it is suitable to use it as an emulsion.

またこの動物用殺菌組成物を局所に撒布することができ
、さらには軟膏としても使用できる。
This antiseptic composition for animals can also be applied topically and can even be used as an ointment.

注射剤、注入剤として使用する際には、通常注射剤、注
入剤に使用される公知の抗生物質注射剤、注入剤で使用
する固体または液体の担体、あるいは稀釈剤と共に混合
して使用することもできる。
When used as an injection or infusion, it should be mixed with a solid or liquid carrier or diluent used in known antibiotic injections or infusions. You can also do it.

このうち、担体としては、水、パラフィン類が最も繁用
される。
Among these, water and paraffins are most frequently used as carriers.

また軟膏として使用する場合には、通常使用される軟膏
基剤と共に使用される。
When used as an ointment, it is used together with a commonly used ointment base.

またこの発明の牛乳房炎用殺菌組成物の投与量は、セフ
ァゾリンもしくはその塩類およびクロキサシリンもしく
はその塩類の混合比、感染症の種類あるいは症状等に応
じて適宜選択されるが、通常例えば泌乳期においては2
00mg/牛位が適当である。
The dosage of the sterilizing composition for bovine mastitis of the present invention is appropriately selected depending on the mixing ratio of cefazolin or its salts and cloxacillin or its salts, the type of infection or symptoms, etc., but usually, for example, during the lactation period. is 2
00mg/cow is appropriate.

次にこの発明の効果を試験例により説明する。Next, the effects of this invention will be explained using test examples.

試験例 1 牛の乳房炎より分離した菌株に対する試験管内発育阻止
試験による併用効果: クロキサシリンおよびセファゾリンの各所定量を含有す
るハートインフエージョン培地を用い、これに各病原菌
の約105/ml(細肪数/ml)を植菌し、37℃で
20時間培養したのち、被検病原菌の生育状況を測定し
た。
Test Example 1 Combined effect on bacterial strains isolated from mastitis in cows by in vitro growth inhibition test: Using Heart Infusion medium containing predetermined amounts of each of cloxacillin and cefazolin, approximately 10 After culturing at 37° C. for 20 hours, the growth status of the pathogenic bacteria to be tested was measured.

結果は次表のとおりで、各表中+は被検菌の生育するこ
とを、一は生育しないことを意味する。
The results are shown in the following table, where + in each table means that the test bacteria grew, and 1 means that the test bacteria did not grow.

次にこの発明の実施例を示す。Next, examples of this invention will be shown.

実施例 1 セファゾリンナトリウム 100mgクロキサ
シリン 100mgラネット・ワック
スS・X(商標) 50mg軟質パラフィン
100mg食用青色 1号
25mg上記を液体パラフィンと混合し全体を3gと
して注入剤とする。
Example 1 Cefazolin sodium 100mg Cloxacillin 100mg Lanette Wax S.X (trademark) 50mg Soft paraffin
100mg food blue No. 1
Mix 25 mg of the above with liquid paraffin to make a total of 3 g and use it as an injection.

Claims (1)

【特許請求の範囲】[Claims] 1 セファゾリンもしくはその塩類1重量部およびクロ
キサシリンもしくはその塩類約1〜1000重量部を含
む牛乳房炎用殺菌組成物。
1. A disinfectant composition for bovine mastitis containing 1 part by weight of cefazolin or a salt thereof and about 1 to 1000 parts by weight of cloxacillin or a salt thereof.
JP3500874A 1974-02-28 1974-03-27 Grasshopper's garden Expired JPS5813526B2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP3500874A JPS5813526B2 (en) 1974-03-27 1974-03-27 Grasshopper's garden
IT6748475A IT1036078B (en) 1974-03-27 1975-02-25 Beta-Lactam antibiotic combination preparations - contg a 7-tetrazolylacetamido-cephem cpd and penicillin
FR7506201A FR2262519B1 (en) 1974-02-28 1975-02-27
DE19752508443 DE2508443C2 (en) 1974-02-28 1975-02-27 Mixed pharmaceutical preparation with antibiotic effect
GB832775A GB1479838A (en) 1974-02-28 1975-02-27 Antibacterial composition
NL7502333A NL180071C (en) 1974-02-28 1975-02-27 METHOD FOR PREPARING MEDICINES WITH AN ANTIBIOTIC ACTIVITY
AU78654/75A AU490435B2 (en) 1975-02-27 Antibacterial composition
CA221,406A CA1038759A (en) 1974-03-27 1975-03-06 Mixtures of cephalosporin and penicillin type antibiotics
DK132675A DK132675A (en) 1974-03-27 1975-03-26

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3500874A JPS5813526B2 (en) 1974-03-27 1974-03-27 Grasshopper's garden

Publications (2)

Publication Number Publication Date
JPS50126816A JPS50126816A (en) 1975-10-06
JPS5813526B2 true JPS5813526B2 (en) 1983-03-14

Family

ID=12430047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3500874A Expired JPS5813526B2 (en) 1974-02-28 1974-03-27 Grasshopper's garden

Country Status (4)

Country Link
JP (1) JPS5813526B2 (en)
CA (1) CA1038759A (en)
DK (1) DK132675A (en)
IT (1) IT1036078B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0214046Y2 (en) * 1983-08-22 1990-04-17
JPH0310514Y2 (en) * 1983-02-15 1991-03-15

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
JPH0582374U (en) * 1992-04-08 1993-11-09 元実 原田 Clothes cover

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0310514Y2 (en) * 1983-02-15 1991-03-15
JPH0214046Y2 (en) * 1983-08-22 1990-04-17

Also Published As

Publication number Publication date
JPS50126816A (en) 1975-10-06
CA1038759A (en) 1978-09-19
DK132675A (en) 1975-09-28
IT1036078B (en) 1979-10-30

Similar Documents

Publication Publication Date Title
Brogden et al. Aztreonam: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use
Sande et al. In vivo antagonism between gentamicin and chloramphenicol in neutropenic mice
Stamm et al. Antimicrobial activity of cefmenoxime (SCE-1365)
Weinstein et al. The effect of urea, urethane and other carbamates on bacterial growth
JPS5813526B2 (en) Grasshopper's garden
IE51846B1 (en) Pharmaceutical preparation for veterinary use and an appliance containing it
JP2893650B2 (en) Stabilizer composition and stabilized aqueous system
US2907693A (en) Antibacterial compositions comprising a tetracycline-type antibiotic and an alkyl phenoxyethoxyethyl dialkylbenzyl ammonium salt
US4199566A (en) Antibacterial composition for medical use
ES2756698T3 (en) Biocidal formulation to protect the skin comprising copper pentahydrate salts and zinc heptahydrate salts
US4133772A (en) Aqueous detergent compositions containing amphoteric surfactants having anti-microbial and preservative properties
JPS633846B2 (en)
US2692845A (en) Composition containing streptomycin glucuronolactone mixture
Weinstein et al. The Action of Urea and Some of its Derivatives on Bacteria: II. The Antibacterial Activity of Combinations of Urea and Urethane with Sulfonamides and the Effect of the Carbamates on Para-Aminobenzoic Acid and on the Solubility of Sulfonamides
US4404189A (en) Synergistic antimicrobial compositions
Schaller In vitro antibacterial activity of different clotrimazole formulations
US4428936A (en) Antibacterial composition for medical use
US3981999A (en) Fish disease treatment
STRAKOSCH et al. Bacteriostatic Effect of Sulfathiazole in Various Ointment Bases
US3141822A (en) Stable compositions of alkali metal salts of synthetic penicillins and polyacetic acids
US3639632A (en) Antimicrobial compositions containing 1 1'-hexamethylenebis (5-(2 - ethylhexyl) biguanide) dihydrochloride and 4-chloro-2-hydroxyphenyl 24 - dichlorophenyl ether
IE36346B1 (en) Antibacterial agents and a process for the preparation thereof
JPS62272970A (en) Control of stable bacteria mix group
Seltzer et al. The Use of Chloramphenicol (Chloromycetin) for Killing Some Penicillin-Streptomycin Resistant Organisms Encountered in Infected Root Canals
BE505709A (en)